The INFUSE-AMI trial ( INFUSE-Anterior Myocardial Infarction ) randomized patients with anterior STEMI undergoing primary percutaneous coronary intervention with bivalirudin anticoagulation within @ h of symptom onset to intralesion ( IL ) bolus abciximab versus no abciximab and to thrombus aspiration versus no aspiration .